Company Bioventix PLC

Equities

BVXP

GB00B4QVDF07

Biotechnology & Medical Research

Market Closed - London S.E. 11:35:11 2024-05-03 am EDT 5-day change 1st Jan Change
4,325 GBX 0.00% Intraday chart for Bioventix PLC -2.81% +0.58%

Business Summary

Bioventix plc is a United Kingdom-based company specializing in the development and commercial supply of high-affinity monoclonal antibodies for applications in clinical diagnostics, such as in automated immunoassays used in blood testing. The antibodies created at the Company are generated in sheep and are of particular benefit where the target is present at low concentration and where conventional monoclonal or polyclonal antibodies have failed to produce a suitable reagent. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes, for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function, and drug abuse. The Company’s products include sheep monoclonal antibodies (SMAs), Pyrene (HOP-G) ELISA Kits, and Pyrene (HOP-G) Lateral Flow Kits. The Company supplies antibody products and services to the majority of multinational clinical diagnostics companies.

Number of employees: 12

Sales per Business

GBP in Million2022Weight2023Weight Delta
Sheep Monoclonal Antibodies
100.0 %
12 100.0 % 13 100.0 % +9.36%

Sales per region

GBP in Million2022Weight2023Weight Delta
Rest of the World
80.0 %
10 82.0 % 10 80.0 % +6.72%
European Union
12.5 %
1 11.3 % 2 12.5 % +20.86%
United Kingdom
7.5 %
1 6.7 % 1 7.5 % +22.22%

Managers

Managers TitleAgeSince
Chief Executive Officer 65 03-12-22
Director of Finance/CFO 65 20-06-30

Members of the board

Members of the board TitleAgeSince
Chairman 64 04-04-25
Chief Executive Officer 65 03-12-22
Director/Board Member 71 14-01-24
Director of Finance/CFO 65 20-06-30
Director/Board Member 59 23-05-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,219,656 4,798,007 ( 91.92 %) 0 91.92 %

Shareholders

NameEquities%Valuation
Sanford DeLand Asset Management Ltd.
14.45 %
754,000 14.45 % 42 M p
Liontrust Investment Partners LLP
11.00 %
574,162 11.00 % 32 M p
Link Fund Solutions Ltd.
6.966 %
363,626 6.966 % 20 M p
297,088 5.692 % 17 M p
Gresham House Asset Management Ltd. (Investment Management)
5.538 %
289,067 5.538 % 16 M p
Gresham House Asset Management Ltd.
4.077 %
212,814 4.077 % 12 M p
Livingbridge EP LLP
3.964 %
206,888 3.964 % 12 M p
Danske Bank A/S (Investment Management)
3.662 %
191,163 3.662 % 11 M p
Rathbones Investment Management Ltd.
3.160 %
164,941 3.160 % 9 M p
Investec Wealth & Investment Ltd.
2.778 %
145,000 2.778 % 8 M p

Company contact information

Bioventix Plc

7 Romans Business Park East Street

GU9 7SX, Farnham

+44 12 5272 8001

http://www.bioventix.com
address Bioventix PLC(BVXP)